Manzano Stephen 4
4 · Amneal Pharmaceuticals, Inc. · Filed Mar 2, 2021
Insider Transaction Report
Form 4
Manzano Stephen
SVP, General Counsel
Transactions
- Exercise/Conversion
Class A Common Stock
2021-02-27+16,490→ 16,490 total - Tax Payment
Class A Common Stock
2021-02-27$5.39/sh−5,796$31,240→ 10,694 total - Exercise/Conversion
Restricted Stock Units
2021-02-27−16,490→ 49,473 total→ Class A Common Stock (16,490 underlying)
Footnotes (4)
- [F1]Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
- [F2]Each restricted stock units represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F3]Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
- [F4]On February 27,2020, the reporting person was granted 65,963 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.